Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT03934398
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
41
1
37.7
1.1

Study Details

Study Description

Brief Summary

The investigators aim to determine the association of dietary intake on cardiovascular disease risk factors among children with overweight and obesity who are being evaluated for elevated blood pressure.

The investigators will also investigate for predictors of vascular function and determine if predictors vary by level of sodium intake.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Cardiovascular Assessments
  • Diagnostic Test: Actigraphy
  • Diagnostic Test: Laboratory assessments
  • Diagnostic Test: Emotional/Behavioral Assessments

Detailed Description

This research is being done to determine if the food or salt eaten can cause arteries to be stiffer and/or not work as well and if it can impact blood pressure over a 24-hour period of time. The investigators also want to determine if there are any risk factors or blood tests that can predict how stiff arteries are or how well arteries function. The investigators hope that the information from this study will help the investigators prevent blood pressure-related cardiovascular disease in children. This knowledge could help shape future guidelines on how to best prevent and treat high blood pressure and heart disease in children.

Study Design

Study Type:
Observational
Actual Enrollment :
41 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth
Actual Study Start Date :
Apr 10, 2019
Actual Primary Completion Date :
May 31, 2022
Actual Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
ReNEW Clinical Cohort

Individuals evaluated in the ReNEW Clinic at Johns Hopkins University who join the ReNEW Clinic Cohort Study are eligible for this cross-sectional study. Tests will be done for all participants which includes Cardiovascular Assessments, Actigraphy and Laboratory assessments.

Diagnostic Test: Cardiovascular Assessments
Participants will undergo the following cardiovascular assessments: 24-hour blood pressure monitoring, arterial stiffness measurements, endothelial function measurements.

Diagnostic Test: Actigraphy
Participants will wear an actigraph device for 7 days to measure participant's activity and sleep.

Diagnostic Test: Laboratory assessments
Participants will provide blood and urine samples for laboratory assessments.

Diagnostic Test: Emotional/Behavioral Assessments
Participants and parents will fill out questionnaires for emotional/behavioral assessments

Outcome Measures

Primary Outcome Measures

  1. Arterial stiffness as assessed by Pulse wave velocity [1 day]

    This will be determined from Pulse wave velocity (m/sec) done at the study visit

  2. Arterial stiffness as assessed by Ambulatory Arterial Stiffness Index (AASI) [1 day]

    The Ambulatory Arterial Stiffness Index will be determined from data obtained from vascular measures and during 24-hour ambulatory blood pressure monitoring. Arterial stiffness increases as the regression slope approaches 0 and the AASI approaches 1.

  3. Arterial stiffness as assessed by Augmentation Index [1 day]

    The Augmentation Index (measured as a percentage) will be determined from a vascular assessment and data obtained during 24-hour ambulatory blood pressure monitoring. A greater Augmentation Index represents a stiffer, less compliant vessel.

  4. Endothelial function as assessed by Laser Doppler flow perfusion [1 day]

    The percent change in mean blood flow will be determined from Laser Doppler flow perfusion measurements obtained using a heating protocol.

  5. Mean Blood pressure (mmHg) [1 day]

    Mean daytime systolic blood pressure in millimeters of mercury (mmHg) will be determined from 24-hour blood pressure monitoring.

Secondary Outcome Measures

  1. Pediatric Adverse Childhood Events (ACEs) score [1 day]

    The Pediatric ACEs questionnaire contains 17 yes or no questions about stressful or traumatic life events. Greater exposure to adverse childhood experiences (ACEs) is associated with poorer physical and mental health. Some researchers have suggested that an ACEs score of greater than or equal to 3 or 4 significantly increases the risk for health problems, however, there is no widely accepted threshold for how many ACEs endorsed is clinically significant or more predictive of these problems.

  2. Children's Emotion Management Scale (CEMS) score [1 day]

    The Children's Emotional management scale is a questionnaire that consists of 33 questions (3 point Likert scale) examining youth's ability to regulate appropriately their negative emotions (i.e. anger, sadness, and worry). Generally, poorer emotion regulation capabilities are associated with poorer health outcomes, with most research looking at CV outcomes in adults.

  3. Behavior Assessment for Children (BASC) score [1 day]

    The Behavior Assessment for Children is a questionnaire that consists of 189 questions (True/False and 4 point Likert scale). It is a broad behavioral screening measure commonly used in child and adolescent psychology and psychiatric settings.It has three primary scales: internalizing (e.g., depression, anxiety), externalizing (e.g., aggression, hyperactivity), and total problems (combination of internalizing and externalizing plus attention problems and withdrawal subscales). Scores between 60-69 are considered "at risk" for clinical problems and scores of 70+ are considered clinically significant presence of those symptoms. Any scores that are not in this range are considered to be within normal limits and not indicative of difficulties.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 22 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Overweight or obese

  • Elevated blood pressure

  • Referred to the ReNEW Clinic at Johns Hopkins University for evaluation and treatment of elevated blood pressure.

Exclusion Criteria:
  • The only children who will not be eligible for inclusion in this study are those who are non-English speaking.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins School of Medicine Division of Pediatric Nephrology Baltimore Maryland United States 21287

Sponsors and Collaborators

  • Johns Hopkins University
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Tammy M Brady, M.D., PhD., Johns Hopkins University Division of Pediatric Nephrology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT03934398
Other Study ID Numbers:
  • IRB00196923
  • 1R56HL139620
First Posted:
May 1, 2019
Last Update Posted:
Jun 22, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2022